Search

Scanning Doppler Lidars have become more prominent in the wind energy industry for a variety of applications. Scanning Lidar’s provide spatial variation of winds and direction over a large area, which can be used to assess the spatial uncertainty of winds and analyze complex flows. Due to the recent growth in wind energy, wind farms are being built in complex terrain areas and fine tuning of the existing wind farms for optimized performance have gained significant interest. Scanning Lidar is an ideal tool for improved assessment of flow over complex terrains and wake characterization of large wind farms. In this article, the various applications of Lidar in the wind industry are discussed and results from several campaigns conducted in US and Europe is presented. The conglomeration of results provided in this article would assist wind energy developers and researchers in making improved decisions about their wind farm operations and pre-construction analysis using scanning Lidar’s.

The accurate localization and characterization of aerosol and cloud layers is crucial for climate studies (aerosol indirect effect), meteorology (Planetary Boundary Layer PBL height), site monitoring (industrial emissions, mining,…) and natural hazards (thunderstorms, volcanic eruptions). LEOSPHERE has recently developed aerosol/cloud detection and characterization on WINDCUBE long range Coherent Wind Doppler Lidars (CWDL). These new features combine wind and backscatter intensity informations (Carrier-to-Noise Ratio CNR) in order to detect (aerosol/cloud base and top, PBL height) and to characterize atmospheric structures (attenuated backscatter, depolarization ratio). For each aerosol/cloud functionality the method is described, limitations are discussed and examples are given to illustrate the performances.

The population of Argentina is the result of the intermixing between several groups, including Indigenous American, European and African populations. Despite the commonly held idea that the population of Argentina is of mostly European origin, multiple studies have shown that this process of admixture had an impact in the entire Argentine population. In the present study we characterized the distribution of Indigenous American, European and African ancestry among individuals from different regions of Argentina and evaluated the level of discrepancy between self-reported grandparental origin and genetic ancestry estimates. A set of 99 autosomal ancestry informative markers (AIMs) was genotyped in a sample of 441 Argentine individuals to estimate genetic ancestry. We used non-parametric tests to evaluate statistical significance. The average ancestry for the Argentine sample overall was 65% European (95%CI: 63-68%), 31% Indigenous American (28-33%) and 4% African (3-4%). We observed statistically significant differences in European ancestry across Argentine regions [Buenos Aires province (BA) 76%, 95%CI: 73-79%; Northeast (NEA) 54%, 95%CI: 49-58%; Northwest (NWA) 33%, 95%CI: 21-41%; South 54%, 95%CI: 49-59%; p<0.0001] as well as between the capital and immediate suburbs of Buenos Aires city compared to more distant suburbs [80% (95%CI: 75-86%) versus 68% (95%CI: 58-77%), p = 0.01]. European ancestry among individuals that declared all grandparents born in Europe was 91% (95%CI: 88-94%) compared to 54% (95%CI: 51-57%) among those with no European grandparents (p<0.001). Our results demonstrate the range of variation in genetic ancestry among Argentine individuals from different regions in the country, highlighting the importance of taking this variation into account in genetic association and admixture mapping studies in this population.

Despite the evidence for a functional role of nitric oxide (NO) in the regulation of uterine contractility in several species, there is little information about the effects of this gas on the mouse uterus. The aims of this study were to investigate if the NO relaxation pathway is present in mouse pregnant uterus and the relationship with the uterotonic prostaglandins (PGs E and F2alpha) production. We evaluated the effect of the treatment with a competitive nitric oxide synthase (NOs) inhibitor: N(G)-monomethyl-L-arginine on the spontaneous contractile activity and prostaglandin production on two different days of pregnancy: second day of pregnancy (preimplantation stage) and on the afternoon of the fifth day of pregnancy (postimplantation stage). We found that only on the fifth day of pregnancy did the inhibitor induce a highly significant isometric developed tension (IDT) and that this effect was maintained throughout the experiment. In order to evaluate if the generation of NO was also different between the two days of pregnancy, NOs activity was measured. Total NOs activity was significantly elevated during the postimplantation stage. We studied the interaction between the NO and cyclooxygenase (COX) pathways on the fifth day of pregnancy, and the data show no stimulation of PGs production by endogenous NO. In summary, we found that NO participates in the control of uterine contractility on the fifth day (a postimplantation stage) and that in this condition the NO was not able to elicit an increase in PGs production.

Embryo prostaglandin (PG) synthesis plays a role in the modulation of embryo metabolism and viability, and in the beginning of the implantation. The effects of ethanol consumption seem to be mediated at least in part by PGs. Increased PG production of postimplantation embryos is associated with retardation and abnormalities in the gestational period. The aim of this study was to find out the effects of low chronic ethanol ingestion by mice, previous to pregnancy, on the PGE released by in vitro and in vivo derived embryos. Immature females or adult males were treated with 5% ethanol for 30 days. After fertilization and mating, two-cell embryos, morulae and blastocysts were collected. The PGE synthesis and release were measured by radioimmunoassay. PGE production by in vitro derived two-cell embryos from ethanol-treated females was lower than in the control group (P < 0.01). Also, PGE production was reduced when two-cell embryos came from ethanol-treated males (P < 0.01). There were no differences in PGE synthesis by in vitro derived morulae and blastocysts in these groups. Two-cell embryos derived from mating produced lower quantities of PGE when they came from ethanol-treated females mated with control males, as compared to the control group. PGE release by in vivo derived blastocysts from ethanol-treated females was reduced significantly, as compared to the control group (P < 0.01). We conclude that a low concentration of ethanol administered chronically to immature females reduces PGE synthesis and release by two-cell embryos from culture in vitro, and by embryos of days 2 and 4 from in vivo development.

The aims of the present study are to find out if preimplantation mice embryos can synthesize prostaglandins and if the presence of the embryos in the uteri modifies the uterine prostaglandin synthesis. Both uteri of adult pregnant mice and embryos were collected at day two, three and four of pregnancy and the synthesis and release of PGE and PGF2 alpha was measured by radioimmunoassay. At day five of pregnancy, embryos are tightly adherent to epithelium, so tied uterine horns (without embryos) were compared to control uteri (with embryos). We found that embryos synthesize PGE and PGF2 alpha and that PGE is significantly greater on the fourth day of pregnancy than on the second and third day (P < 0.001). In the uteri, during the four days of pregnancy, there is a significant increase in PGE (P < 0.05) and a significant decrease in PGF2 alpha (P < 0.01). On the fifth day, the synthesis of PGF2 alpha was significantly greater in tied uteri than in controls (P < 0.05). We conclude that mice embryos can synthesize prostaglandins and their presence in uteri significantly decreased the synthesis of PGF2 alpha during the peri-implantation period without modifying the production of PGE.

Cumulus-oocyte complexes, obtained from superovulated Balb/C virgin female mice, released to the incubation media significant amounts of PGE1, PGE2 and PGF2 alpha, as estimated by bioassay. Fertilization rates in vitro decreased sharply when cumulus-oocyte complexes were treated with indomethacin (10(-6) M) and then inseminated with 5000 sperm per oocyte. In order to explore if the reduced prostaglandin (PG) concentration was responsible for diminished fertilization rates, PGE1, PGE2 and PGF2 alpha (10(-9) M) were added to the fertilization media of treated oocytes. PGE1 and PGE2 but not PGF2 alpha returned fertilization rates to control levels. Besides, PGE1 (10(-9) M) enhanced fertilization rates with reduced sperm numbers (1000 sperm per oocyte) of untreated cumulus-oocyte complexes. In conclusion, PG synthesis and release of mouse cumulus-oocyte complexes affects fertilization in vitro, and it is suggested that PGs of the E series modulate sperm function at the moment of fertilization.

Nitric oxide (NO) has recently been found to function as an intra and extra cellular messenger by activating guanylate cyclase. Its role in sperm hyperactivation was examined by adding to the capacitating medium a classical donor of NO (Sodium nitroprusside, NP) in two different concentrations (150 microM and 300 microM). In both treatments, the percentage of motile cells was evaluated, showing a significant decrease on motility and viability at 90 and 120 minutes when sodium nitroprusside was used in a concentration of 300 microM; no modifications were observed with 150 microM. The effect obtained with 300 microM of sodium nitroprusside was avoided by hemoglobin (20 micrograms/ml), a scavenger of the NO. The percentage of hyperactivated spermatozoa in the presence of 300 microM sodium nitroprusside increased significantly more than the control during the first 30 and 60 minutes of capacitation; but with 150 microM sodium nitroprusside a significant increase was observed at 60 and 90 minutes of incubation. Thus, the data strongly suggests that nitric oxide plays an important role in sperm hyperactivation "in vitro".